Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a glossary toggle and updated QC metadata label to 'Last Update Submitted that Met QC Criteria' with a revision bump to v3.4.0. The old 'Last Update Submitted that met QC Criteria' label capitalization was replaced and the 'No FEAR Act data' label was replaced with 'No FEAR Act Data'.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page’s Locations section has been expanded to include a large list of study sites across the United States, Canada, and several European countries. The HHS Vulnerability Disclosure notice has been removed.SummaryDifference2%

- Check69 days agoChange DetectedPubMed publication attribution text was updated to state that publications are auto-filled from PubMed, and a new Revision: v3.3.2 was added. The older PubMed attribution sentence and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check76 days agoChange DetectedRemoved the notice about a lapse in government funding and the NIH Clinical Center's operating status, which previously informed users that updates may be delayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedNo additions or deletions detected on the Study Details page (NCT02132949 BERENICE); the content and layout appear the same across screenshots.SummaryDifference0.2%

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.